NCT06517576View on ClinicalTrials.gov

Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes

NAEnrolling by invitationINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

Blood glucose monitor with Digital Platform and Health Coaching

Blood glucose monitors will be used daily to measure blood glucose measurements.

DEVICE

Continuous glucose monitor

Continuous glucose monitors will be used daily to measure blood glucose measurements.

OTHER

Usual Care

Usual care for type 2 diabetes

Trial Locations (1)

60623

Lawndale Christian Health Center, Chicago

All Listed Sponsors
collaborator

Northwestern University Feinberg School of Medicine

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

University of Chicago

OTHER

lead

Lawndale Christian Health Center

OTHER